PharmaTimesOriginal article
Koala trial doses first patient with novel KMA‑targeting CAR‑T
Trial StartKMA-targeting CAR-TPositive
AI Analysis
Summary
Koala has dosed the first patient in a first-in-human trial of a novel KMA-targeting CAR-T cell therapy for multiple myeloma, with Australian teams advancing the program.
Clinical Trial Data
Phase
Phase_1
Patients
1
Outcome Details
First patient dosed in first-in-human trial
Importance:6/10
Sentiment:
0.50
CAR-Toncologymultiple myelomafirst-in-humancell therapy
Related Companies
Read the original article
Published by PharmaTimes on September 2, 2026 7:38 AM